Skip to main content
Signal8
Balachandran Madhavan profile photo

Madhavan Balachandran

CIK: 0001555508

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)7 (43.8%)

Position reduction

Option Exercises (M)3 (18.8%)

Derivative conversions

Awards (A)6 (37.5%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (3)

Stevanato Group S.p.A. logo
STVN

Stevanato Group S.p.A.

Director
uniQure N.V. logo
QURE

uniQure N.V.

Director
Replimune Group, Inc. logo
REPL

Replimune Group, Inc.

Director

Discretionary Trading P&L

Holdings

Transaction History (16 total)

  • uniQure N.V. logo
    QURE

    uniQure N.V.

    Jun 17, 2026
    Exercise(M)
    Direct
    6.4K shares at avg. $19.39$124K
  • uniQure N.V. logo
    QURE

    uniQure N.V.

    Jun 17, 2026
    Sale(S)
    Direct
    1.7K shares at avg. $42.60$72K
  • uniQure N.V. logo
    QURE

    uniQure N.V.

    Jun 17, 2026
    Sale(S)
    Direct
    4.7K shares at avg. $43.66$205K
  • uniQure N.V. logo
    QURE

    uniQure N.V.

    Jun 17, 2026
    Sale(S)
    Direct
    5.3K shares at avg. $47.08$249K
  • uniQure N.V. logo
    QURE

    uniQure N.V.

    Jun 17, 2026
    Exercise(M)
    Direct
    5.3K shares at avg. $31.71$168K
  • Stevanato Group S.p.A. logo
    STVN

    Stevanato Group S.p.A.

    Jun 15, 2026
    Sale(S)
    Direct
    1.5K shares at avg. $17.09$26K
  • uniQure N.V. logo
    QURE

    uniQure N.V.

    Jun 15, 2026
    Sale(S)
    Direct
    10K shares at avg. $27.85$279K
  • uniQure N.V. logo
    QURE

    uniQure N.V.

    Jun 15, 2026
    Exercise(M)
    Direct
    10K shares at avg. $8.49$85K
  • Stevanato Group S.p.A. logo
    STVN

    Stevanato Group S.p.A.

    Jun 12, 2026
    Award(A)
    Direct
    5K shares-
  • uniQure N.V. logo
    QURE

    uniQure N.V.

    Jun 11, 2026
    Sale(S)
    Direct
    2K shares at avg. $27.06$54K
  • uniQure N.V. logo
    QURE

    uniQure N.V.

    Jun 10, 2026
    Award(A)
    Direct
    7.6K shares-
  • Replimune Group, Inc. logo
    REPL

    Replimune Group, Inc.

    Apr 1, 2026
    Award(A)

    Stock Option (right to buy)

    Direct
    44.5K shares-
  • uniQure N.V. logo
    QURE

    uniQure N.V.

    Jun 20, 2025
    Sale(S)
    Direct
    2.1K shares at avg. $14.45$31K
  • uniQure N.V. logo
    QURE

    uniQure N.V.

    Jun 11, 2025
    Award(A)
    Direct
    8K shares-
  • Replimune Group, Inc. logo
    REPL

    Replimune Group, Inc.

    Apr 1, 2025
    Award(A)

    Stock Option (right to buy)

    Direct
    32K shares-
  • Replimune Group, Inc. logo
    REPL

    Replimune Group, Inc.

    Sep 4, 2024
    Award(A)

    Employee Stock Option (right to buy)

    Direct
    64K shares-

1-16 of 16

About Balachandran Madhavan

Balachandran Madhavan (SEC CIK 0001555508) files insider reports with the SEC as Director of Stevanato Group S.p.A. (STVN), Director of uniQure N.V. (QURE) and Director of Replimune Group, Inc. (REPL).

Signal8 holds 11 ownership filings by Balachandran Madhavan (2 Form 3, 9 Form 4), filed between Sep 5, 2024 and Jun 26, 2026. Those filings report 16 transactions, from Sep 4, 2024 to Jun 17, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Balachandran Madhavan's filings is in AMSTERDAM.

Recent filings by Balachandran Madhavan

  • Jun 17, 2026: Option exercise of QURE shares (Form 4, code M).
  • Jun 17, 2026: Open-market sales of QURE shares (3 lines, Form 4, code S).
  • Jun 17, 2026: Option exercise of QURE shares (Form 4, code M).
  • Jun 15, 2026: Open-market sale of STVN shares (Form 4, code S).
  • Jun 15, 2026: Open-market sale of QURE shares (Form 4, code S).

Other insiders filing for Stevanato Group S.p.A. (STVN)

How to read Form 4 transaction codes